Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Phenobarbital sodium 100mg/5ml oral liquid
0408010P0AABHBH
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 10mg/5ml oral liquid
0408010P0AABBBB
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 11mg/5ml oral liquid
0408010P0AABFBF
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 125mg/5ml oral liquid
0408010P0AABABA
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 15mg/5ml oral liquid
0408010P0AAAYAY
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 17mg/5ml oral liquid
0408010P0AABGBG
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 30mg/5ml oral liquid
0408010P0AABCBC
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 35mg/5ml oral liquid
0408010P0AABLBL
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 36mg/5ml oral liquid
0408010P0AABEBE
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 45mg/5ml oral liquid
0408010P0AABMBM
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 55mg/5ml oral liquid
0408010P0AABNBN
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 5mg/5ml oral liquid
0408010P0AABPBP
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 60mg/5ml oral liquid
0408010P0AAAZAZ
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 7.5mg/5ml oral liquid
0408010P0AABJBJ
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium powder
190400000AAMKMK
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Phenol 0.71% mouthwash sugar free
1203040K0AAAGAG
|
Phenol (Mouthwash) | Phenol | Ear, Nose and Oropharynx | No data available |
|
Phenol 1.2% / Chlorhexidine gluconate 0.25% spray
1310050P0AAAEAE
|
Phenol (Topical) | Phenol | Skin | No data available |
|
Phenol 2% in Aqueous calamine cream
1310050P0AAAFAF
|
Phenol (Topical) | Phenol | Skin | No data available |
|
Phenol crystals
190400000AAAPAP
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Phenolphthalein yellow 120mg / Rhubarb 27.5mg tablets
0106020U0AAAAAA
|
Phenolphthalein/rhubarb | Phenolphthalein and rhubarb | Gastro-Intestinal System | No data available |
|
Phenothrin 0.2% lotion
1310040S0AAABAB
|
Phenothrin | Phenothrin | Skin | No data available |
|
Phenothrin 0.5% foam
1310040S0AAADAD
|
Phenothrin | Phenothrin | Skin | No data available |
|
Phenothrin 0.5% liquid
1310040S0AAACAC
|
Phenothrin | Phenothrin | Skin | No data available |
|
Phenoxybenzamine 100mg/2ml solution for infusion ampoules
0205040M0AAADAD
|
Phenoxybenzamine hydrochloride | Phenoxybenzamine hydrochloride | Cardiovascular System | No data available |
|
Phenoxybenzamine 10mg/5ml oral liquid
0205040M0AAANAN
|
Phenoxybenzamine hydrochloride | Phenoxybenzamine hydrochloride | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.